Friedrich Mittermayer

2.1k total citations
43 papers, 1.7k citations indexed

About

Friedrich Mittermayer is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Friedrich Mittermayer has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 21 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Friedrich Mittermayer's work include Nitric Oxide and Endothelin Effects (18 papers), Cardiovascular Issues in Pregnancy (12 papers) and Cardiovascular Function and Risk Factors (6 papers). Friedrich Mittermayer is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Cardiovascular Issues in Pregnancy (12 papers) and Cardiovascular Function and Risk Factors (6 papers). Friedrich Mittermayer collaborates with scholars based in Austria, United Kingdom and United States. Friedrich Mittermayer's co-authors include Michael Wolzt, Katarzyna Krzyżanowska, Georg Schaller, Johannes Pleiner, Guntram Schernthaner, Dominik G. Haider, Walter Krugluger, Raymond J. MacAllister, Claudia Marsik and Stylianos Kapiotis and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Friedrich Mittermayer

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friedrich Mittermayer Austria 25 674 651 415 225 221 43 1.7k
Katarzyna Krzyżanowska Austria 19 726 1.1× 572 0.9× 606 1.5× 198 0.9× 268 1.2× 31 1.7k
Norio Komai Japan 17 429 0.6× 539 0.8× 463 1.1× 207 0.9× 177 0.8× 26 1.5k
Erdinç Çakır Türkiye 25 332 0.5× 453 0.7× 458 1.1× 377 1.7× 356 1.6× 68 2.2k
Jessica Cronin United States 9 600 0.9× 959 1.5× 347 0.8× 266 1.2× 215 1.0× 10 2.0k
Marcus Baumann Germany 26 304 0.5× 696 1.1× 319 0.8× 501 2.2× 269 1.2× 94 2.1k
Markus Stühlinger Austria 16 913 1.4× 1.1k 1.7× 145 0.3× 236 1.0× 285 1.3× 43 2.2k
Francesco Rapisarda Italy 20 333 0.5× 933 1.4× 562 1.4× 170 0.8× 268 1.2× 45 2.0k
Tayfun Eyıleten Türkiye 33 443 0.7× 869 1.3× 502 1.2× 362 1.6× 504 2.3× 71 3.1k
Raffaele Maio Italy 25 450 0.7× 1.0k 1.6× 299 0.7× 353 1.6× 231 1.0× 79 2.2k
Fu‐Mei Chung Taiwan 22 534 0.8× 627 1.0× 939 2.3× 367 1.6× 301 1.4× 62 2.2k

Countries citing papers authored by Friedrich Mittermayer

Since Specialization
Citations

This map shows the geographic impact of Friedrich Mittermayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Mittermayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Mittermayer more than expected).

Fields of papers citing papers by Friedrich Mittermayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Mittermayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Mittermayer. The network helps show where Friedrich Mittermayer may publish in the future.

Co-authorship network of co-authors of Friedrich Mittermayer

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Mittermayer. A scholar is included among the top collaborators of Friedrich Mittermayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Mittermayer. Friedrich Mittermayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mittermayer, Friedrich, et al.. (2015). Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development. Current Diabetes Reviews. 11(1). 17–31. 39 indexed citations
2.
Mittermayer, Friedrich, et al.. (2014). Successful Management of Type 2 Diabetes with Lifestyle Intervention: A Case Report. International Journal for Vitamin and Nutrition Research. 84(3-4). 133–139. 2 indexed citations
3.
Krzyżanowska, Katarzyna, Yoshimasa Aso, Friedrich Mittermayer, et al.. (2009). High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Translational research. 153(4). 199–203. 15 indexed citations
4.
Mittermayer, Friedrich, et al.. (2008). Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure. Translational research. 152(1). 24–30. 11 indexed citations
5.
Skoro‐Sajer, Nika, Friedrich Mittermayer, Adelheid Panzenboeck, et al.. (2007). Asymmetric Dimethylarginine is Increased in Chronic Thromboembolic Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 176(11). 1154–1160. 90 indexed citations
6.
Pleiner, Johannes, Friedrich Mittermayer, Herbert Langenberger, et al.. (2007). Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes. Wiener klinische Wochenschrift. 119(15-16). 483–489. 22 indexed citations
7.
Schaller, Georg, Johannes Pleiner, Friedrich Mittermayer, et al.. (2007). Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans. Critical Care Medicine. 35(8). 1869–1875. 13 indexed citations
8.
Mittermayer, Friedrich, Georg Schaller, Johannes Pleiner, et al.. (2007). Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction. The Journal of Clinical Endocrinology & Metabolism. 92(7). 2574–2580. 32 indexed citations
9.
Heutling, Dennis, H Schulz, P Kaltwaßer, et al.. (2007). Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment. The Journal of Clinical Endocrinology & Metabolism. 93(1). 82–90. 98 indexed citations
10.
Haider, Dominik G., Friedrich Mittermayer, Georg Schaller, et al.. (2006). Free fatty acids normalize a rosiglitazone-induced visfatin release. American Journal of Physiology-Endocrinology and Metabolism. 291(5). E885–E890. 34 indexed citations
11.
Ziegler, Sophie, Georg Schaller, Friedrich Mittermayer, et al.. (2006). Exercise Training Improves Low-Density Lipoprotein Oxidability in Untrained Subjects With Coronary Artery Disease. Archives of Physical Medicine and Rehabilitation. 87(2). 265–269. 19 indexed citations
12.
Mittermayer, Friedrich, Katarzyna Krzyżanowska, Markus Exner, et al.. (2006). Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 26(11). 2536–2540. 119 indexed citations
13.
Krzyżanowska, Katarzyna, Friedrich Mittermayer, Walter Krugluger, et al.. (2006). Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis. 189(1). 236–240. 55 indexed citations
14.
Schaller, Georg, Barbara Scheiber‐Mojdehkar, Michael Wolzt, et al.. (2005). Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. Kidney International. 68(6). 2814–2822. 24 indexed citations
15.
Mittermayer, Friedrich, Johannes Pleiner, Georg Schaller, et al.. (2005). Tetrahydrobiopterin correctsEscherichia coliendotoxin-induced endothelial dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 289(4). H1752–H1757. 39 indexed citations
16.
Marsik, Claudia, et al.. (2005). Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level. Clinical Immunology. 114(3). 293–298. 6 indexed citations
17.
Mittermayer, Friedrich, Khodadad Namiranian, Johannes Pleiner, Georg Schaller, & Michael Wolzt. (2004). Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans. Clinical Science. 106(6). 577–581. 50 indexed citations
18.
Mittermayer, Friedrich, Johannes Pleiner, Georg Schaller, et al.. (2004). 1027-196 Tetrahydrobiopterin corrects escherichia coli endotoxin-induced endothelial dysfunction. Journal of the American College of Cardiology. 43(5). A452–A452. 4 indexed citations
19.
Langenberger, Herbert, Georg Schaller, Johannes Pleiner, et al.. (2003). C‐peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans. British Journal of Clinical Pharmacology. 55(6). 526–530. 1 indexed citations
20.
Pleiner, Johannes, Georg Schaller, Friedrich Mittermayer, et al.. (2002). FFA-Induced Endothelial Dysfunction Can Be Corrected by Vitamin C. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2913–2917. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Krzyżanowska Breakdown of academic impact, for papers by Norio Komai Breakdown of academic impact, for papers by Erdinç Çakır Breakdown of academic impact, for papers by Jessica Cronin Breakdown of academic impact, for papers by Marcus Baumann Breakdown of academic impact, for papers by Markus Stühlinger Breakdown of academic impact, for papers by Francesco Rapisarda Breakdown of academic impact, for papers by Tayfun Eyıleten Breakdown of academic impact, for papers by Raffaele Maio Breakdown of academic impact, for papers by Fu‐Mei Chung
Rankless by CCL
2026